Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis.

CONCLUSION: DHM improves CCl4-induced CLI and regulates the pyroptosis pathway in hepatocytes. DHM may be a potential therapeutic agent for CLI.
PMID: 33244197 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - November 7, 2020 Category: Gastroenterology Authors: Cheng QC, Fan J, Deng XW, Liu HC, Ding HR, Fang X, Wang JW, Chen CH, Zhang WG Tags: World J Gastroenterol Source Type: research